KKR said it has agreed to acquire a controlling stake in cancer treatment chain HealthCare Global Enterprises Ltd (HCG) from fellow private equity firm CVC for ₹445 per share, amounting to around $400 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback